Survey: Most Trial Sites Reducing In-Person Visits to Quell Patient Fears During Pandemic
Approximately 51 percent of patients in clinical trials are concerned about coming into contact with other participants who may have COVID-19, prompting nearly 83 percent of U.S. sites to adjust patient scheduling to limit the number of participants in the office at the same time, according to a survey of 268 U.S. clinical trial sites.
The survey, conducted by SubjectWell and Reify Health, also found that approximately 85 percent of sites in the U.S. are offering phone screenings before in-person visits to reduce the number of participants coming into the office. Almost 93 percent and 91 percent of sites have implemented protocols to keep infected staff and patients out of the office, respectively.
Nearly all sites (96 percent) have also said they have increased sanitation procedures during the COVID-19 pandemic. Additionally, almost 90 percent of surveyed sites reported increasing their supply of personal protective equipment for in-office staff. Around 88 percent of site respondents also said they are using in-office temperature screenings.